Literature DB >> 8548799

The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.

R Hiramatsu1, K Akagi, M Matsuoka, K Sakumi, H Nakamura, L Kingsbury, C David, R R Hardy, K Yamamura, H Sakano.   

Abstract

Using transgenic substrates, we found that the immunoglobulin kappa gene 3' enhancer (E3') acts as a negative regulator in V kappa-J kappa joining. Although the E3' was originally identified as a transcriptional enhancer, it acts in a suppressive manner for recombinational regulation. Base substitution analysis has shown that the PU.1-binding site within the E3' regulates the B/T specificity of V kappa-J kappa joining. In a substrate with a mutated PU.1-binding site (GAGGAA to TCTTCG), V kappa-J kappa joining occurred not only in B cells, but also in T cells. The E3' region is also responsible for determining the pro-B/pre-B specificity of V kappa-J kappa joining. When the E3' region was deleted, kappa gene rearrangement actively occurred at the early pro-B stage of B cell development: nongermline (N) nucleotides were common at recombination junctions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548799     DOI: 10.1016/0092-8674(95)90138-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  10 in total

1.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Octamer independent activation of transcription from the kappa immunoglobulin germline promoter.

Authors:  A Prabhu; D P O'Brien; G L Weisner; R Fulton; B Van Ness
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

3.  PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

Authors:  J M Pongubala; M L Atchison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation.

Authors:  D P O'Brien; E M Oltz; B G Van Ness
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  A conserved sequence block in murine and human T cell receptor (TCR) Jalpha region is a composite element that enhances TCR alpha enhancer activity and binds multiple nuclear factors.

Authors:  C L Kuo; M L Chen; K Wang; C K Chou; B Vernooij; D Seto; B F Koop; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Junctional diversity in signal joints from T cell receptor beta and delta loci via terminal deoxynucleotidyl transferase and exonucleolytic activity.

Authors:  S Candéias; K Muegge; S K Durum
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions.

Authors:  E Sakai; A Bottaro; L Davidson; B P Sleckman; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.

Authors:  M C Roque; P A Smith; V C Blasquez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.

Authors:  Fang Wei; Kristina Zaprazna; Junwen Wang; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

10.  Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.

Authors:  Bart G Jones; Robert E Sealy; Rhiannon R Penkert; Sherri L Surman; Robert W Maul; Geoff Neale; Beisi Xu; Patricia J Gearhart; Julia L Hurwitz
Journal:  Int Immunol       Date:  2019-03-05       Impact factor: 5.071

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.